CIK 0001124524 · Accelerated filer
Cryoport, Inc.
Sign in to watch- Ticker
- CYRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 880313393
- Phone
- (949) 232-1900
- Business address
- 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD, TN, 37027
- Former names
- CRYOPORT SYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,702,237
- in 2 filings, $1.5M under 10b5-1 plans
Net −$1,702,237. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-05 | Hariri Robert J Director | Grant or award | +10,350 | 61,625 | ||
| 2026-06-05 | Hariri Robert J Director | Grant or award · Option (Right to Buy Common Stock) | +16,077 | 16,077 | ||
| 2026-06-05 | Mandalam Ramkumar Director | Grant or award | +10,350 | 91,108 | ||
| 2026-06-05 | Mandalam Ramkumar Director | Grant or award · Option (Right to Buy Common Stock) | +16,077 | 16,077 | ||
| 2026-06-04 | STEFANOVICH ROBERT Chief Financial Officer | Sale | −169,427 | $16.27 | $2.8M | 109,850 |
| 2026-04-21 | SHELTON JERRELL President, CEO | Option exercise | +104,007 | $1.87 | $194K | 1,230,614 |
| 2026-04-21 | SHELTON JERRELL President, CEO | Option exercise · Options to purchase common stock | −104,007 | 0 | ||
| 2026-04-06 | SHELTON JERRELL President, CEO | Option exercise | +50,000 | $1.87 | $94K | 1,126,607 |
| 2026-04-06 | SHELTON JERRELL President, CEO | Option exercise · Options to purchase common stock | −50,000 | 104,007 | ||
| 2026-03-23 | STEFANOVICH ROBERT Chief Financial Officer | Sale | −1,094 | $8.18 | $9K | 279,277 |
| 2026-03-23 | SHELTON JERRELL President, CEO | Sale | −2,894 | $8.18 | $24K | 1,051,607 |
| 2026-03-23 | SHELTON JERRELL President, CEO | Option exercise | +25,000 | $1.87 | $47K | 1,076,607 |
| 2026-03-23 | SHELTON JERRELL President, CEO | Option exercise · Options to purchase common stock | −25,000 | 154,007 | ||
| 2026-03-23 | Sawicki Mark W Chief Scientific Officer | Sale | −1,341 | $8.18 | $11K | 102,356 |
| 2026-03-16 | ZECCHINI EDWARD J See Remarks | Sale | −2,014 | $8.00 | $16K | 109,719 |
| 2026-03-16 | SHELTON JERRELL President, CEO | Sale | −7,918 | $8.00 | $63K | 1,054,501 |
| 2026-03-16 | Sawicki Mark W Chief Scientific Officer | Sale | −3,235 | $8.00 | $26K | 103,697 |
| 2026-03-16 | STEFANOVICH ROBERT Chief Financial Officer | Sale | −2,743 | $8.00 | $22K | 280,371 |
| 2026-03-14 | ZECCHINI EDWARD J See Remarks | Grant or award | +21,322 | 111,733 | ||
| 2026-03-14 | ZECCHINI EDWARD J See Remarks | Grant or award · Stock Option (right to buy) | +63,965 | 63,965 |
Page 2 of 13 · 254 trades